United States
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 26.73 B
|
Sept. 30, 2024 | USD 543.74 | 0.48% |
|
United States |
|
2 |
USD 19.17 B
|
Sept. 30, 2024 | USD 99.65 | -1.32% |
|
United States |
|
3 |
USD 13.96 B
|
Sept. 30, 2024 | USD 305.79 | -0.78% |
|
United States |
|
4 |
USD 4.82 B
|
Sept. 30, 2024 | USD 593.73 | 1.48% |
|
United States |
|
5 |
USD 4.30 B
|
Sept. 30, 2024 | USD 127.63 | -1.27% |
|
United States |
|
6 |
USD 2.60 B
|
Sept. 30, 2024 | USD 162.00 | 3.15% |
|
United States |
|
7 |
USD 2.57 B
|
Sept. 30, 2024 | USD 124.03 | 2.62% |
|
United States |
|
8 |
USD 2.13 B
|
Sept. 30, 2024 | USD 184.16 | -0.85% |
|
United States |
|
9 |
USD 1.92 B
|
Sept. 30, 2024 | USD 30.62 | 0.39% |
|
United States |
|
10 |
USD 1.82 B
|
Sept. 30, 2024 | USD 294.03 | -0.14% |
|
United States |
|
11 |
USD 1.17 B
|
Sept. 30, 2024 | USD 2.91 | -3.32% |
|
United States |
|
12 |
USD 1.12 B
|
Sept. 30, 2024 | USD 93.06 | 0.54% |
|
United States |
|
13 |
USD 1.01 B
|
Sept. 30, 2024 | USD 23.67 | -0.80% |
|
United States |
|
14 |
USD 860.88 M
|
Sept. 30, 2024 | USD 18.92 | 0.64% |
|
United States |
|
15 |
USD 663.49 M
|
Sept. 30, 2024 | USD 44.37 | -2.29% |
|
United States |
|
16 |
USD 610.70 M
|
Sept. 30, 2024 | USD 65.65 | -1.41% |
|
United States |
|
17 |
USD 513.10 M
|
Sept. 30, 2024 | USD 19.85 | -6.19% |
|
United States |
|
18 |
USD 466.02 M
|
Sept. 30, 2024 | USD 14.74 | 1.17% |
|
United States |
|
19 |
USD 407.20 M
|
Sept. 30, 2024 | USD 17.80 | 3.01% |
|
United States |
|
20 |
USD 385.02 M
|
Sept. 30, 2024 | USD 28.72 | 3.61% |
|
United States |
|
21 |
USD 364.01 M
|
Sept. 30, 2024 | USD 133.50 | 0.88% |
|
United States |
|
22 |
USD 266.44 M
|
Sept. 30, 2024 | USD 26.12 | -5.40% |
|
United States |
|
23 |
USD 211.17 M
|
Sept. 30, 2024 | USD 97.73 | 0.74% |
|
United States |
|
24 |
USD 198.21 M
|
Sept. 30, 2024 | USD 91.98 | 0.01% |
|
United States |
|
25 |
USD 138.79 M
|
Sept. 30, 2024 | USD 31.19 | 3.00% |
|
United States |
|
26 |
USD 100.67 M
|
Sept. 30, 2024 | USD 7.82 | 0.51% |
|
United States |
|
27 |
USD 96.60 M
|
Sept. 30, 2024 | USD 15.83 | 0.19% |
|
United States |
|
28 |
USD 67.08 M
|
Sept. 30, 2024 | USD 88.70 | -0.64% |
|
United States |
|
29 |
USD 65.01 M
|
Sept. 30, 2024 | USD 4.09 | 1.74% |
|
United States |
|
30 |
USD 64.95 M
|
Sept. 30, 2024 | USD 11.18 | -9.77% |
|
United States |
|
31 |
USD 41.47 M
|
Sept. 30, 2024 | USD 26.51 | 1.07% |
|
United States |
|
32 |
USD 20.98 M
|
Sept. 30, 2024 | USD 18.16 | -0.17% |
|
United States |
|
33 |
USD 19.16 M
|
Sept. 30, 2024 | USD 5.93 | -10.83% |
|
United States |
|
34 |
USD 17.75 M
|
Sept. 30, 2024 | USD 7.87 | -0.51% |
|
United States |
|
35 |
USD 11.01 M
|
Sept. 30, 2024 | USD 3.05 | -0.33% |
|
United States |
|
36 |
USD 7.95 M
|
Sept. 30, 2024 | USD 32.00 | 4.03% |
|
United States |
|
37 |
USD 6.55 M
|
Sept. 28, 2024 | USD 4.51 | 1.58% |
|
United States |
|
38 |
USD 3.51 M
|
Sept. 30, 2024 | USD 10.22 | -1.06% |
|
United States |
|
39 |
USD 1.80 M
|
Sept. 30, 2024 | USD 2.08 | 3.48% |
|
United States |
|
40 |
USD -439.00 K
|
Sept. 30, 2024 | USD 13.78 | 9.11% |
|
United States |
|
41 |
USD -2.97 M
|
Oct. 31, 2024 | USD 3.63 | -3.20% |
|
United States |
|
42 |
USD -3.46 M
|
Sept. 30, 2024 | USD 1.70 | -0.58% |
|
United States |
|
43 |
USD -10.64 M
|
Sept. 30, 2024 | USD 21.27 | 0.90% |
|
United States |
|
44 |
USD -12.05 M
|
Sept. 30, 2024 | USD 3.35 | 3.08% |
|
United States |
|
45 |
USD -14.19 M
|
Sept. 30, 2023 | USD 1.21 | NA |
|
United States |
|
46 |
USD -77.82 M
|
Sept. 30, 2024 | USD 7.37 | 0.96% |
|
United States |
|
47 |
USD -141.30 M
|
Nov. 30, 2024 | USD 6.84 | 0.15% |
|
United States |
|
48 |
USD -192.04 M
|
Sept. 30, 2024 | USD 13.66 | 2.63% |
|
United States |
|
49 |
USD -555.71 M
|
Sept. 30, 2024 | USD 9.36 | -3.50% |
|
United States |
The Hospitals & Clinics company in United States with the highest EBITDA is UnitedHealth Group Incorporated (NYSE: UNH) at USD 26.73 B.
The Hospitals & Clinics company in United States with the lowest EBITDA is Teladoc Health, Inc. (NYSE: TDOC) at USD -555.71 M.
The top 10 Hospitals & Clinics companies in United States by EBITDA are UnitedHealth Group Incorporated, Merck & Co., Inc., HCA Healthcare, Inc., McKesson Corporation, Tenet Healthcare Corporation, DaVita Inc., Cardinal Health, Inc., Universal Health Services, Inc., Baxter International Inc. and Molina Healthcare, Inc..
The bottom 10 Hospitals & Clinics companies in United States by EBITDA are Teladoc Health, Inc., Pediatrix Medical Group, Inc., Accolade, Inc., NeueHealth, Inc., IMAC Holdings, Inc., Avalon GloboCare Corp., TruBridge, Inc., SCWorx Corp., Streamline Health Solutions, Inc. and NeoGenomics, Inc..